Table 4.
Association of TyG and TyG-NLR indicators with all-cause mortality.
| Q1 | Q2 | Q3 | Q4 | P for trend | |
|---|---|---|---|---|---|
| TyG | |||||
| Model 1 | Ref | 1.93(1.47–3.09) | 2.08(1.37–2.85) | 3.73(2.64–5.31) | < 0.001 |
| Model 2 | Ref | 1.15(0.84–1.71) | 0.92(0.64–1.22) | 1.31(1.03–2.15) | 0.057 |
| Model 3 | Ref | 1.08(0.65–1.53) | 0.79(0.51–1.15) | 1.02(0.62–1.48) | 0.728 |
| TyG-NLR | |||||
| Model 1 | Ref | 0.75(0.46-1.18) | 1.71(1.08-2.61) | 3.27(2.11-4.27) | < 0.001 |
| Model 2 | Ref | 0.71(0.41-1.10) | 1.25(0.79-1.84) | 1.82(1.14-2.57) | < 0.001 |
| Model 3 | Ref | 1.05(1.01-1.24) | 1.19(1.05-1.84) | 1.63(1.08-2.54) | < 0.001 |
Model 1: crude model; Model 2: Adjusted for sex and age; Model 3: Adjusted for sex, age, race, PIR, educational levels, BMI, smoking status, alcohol consumption, hypertension, diabetes mellitus, hyperlipidemia, cancers, lipid-lowering drugs, ALT, and AST; TyG: triglyceride-glucose; NLR: neutrophil-lymphocyte ratio; CI: confidence interval; Ref: reference; PIR: poverty income ratio; BMI: body mass index;ALT: alanine aminotransferase; AST: aspartate aminotransferase.